Company Filing History:
Years Active: 1987-1989
Title: Jeanette Dilley: Innovator in Monoclonal Antibody Research
Introduction
Jeanette Dilley is a prominent inventor based in Mt. View, CA (US). She has made significant contributions to the field of immunotherapy, particularly through her work on monoclonal anti-idiotype antibodies. With a total of 2 patents, her research has the potential to transform treatment options for patients with B-cell tumors.
Latest Patents
Dilley's latest patents focus on monoclonal anti-idiotype antibodies against cell surface immunoglobulin of human B-cell tumors. These patents include labeled conjugates of such antibodies, immunotherapeutic compositions containing these antibodies, and a process for their production. Notably, her research has demonstrated that a patient treated with a monoclonal anti-idiotype antibody against the cell surface IgM of their tumor experienced complete remission of nodular lymphoma.
Career Highlights
Jeanette Dilley is affiliated with Leland Stanford Junior University, where she continues her groundbreaking research. Her work has garnered attention for its innovative approach to cancer treatment, particularly in the realm of immunotherapy.
Collaborations
Dilley has collaborated with notable figures in her field, including Ronald Levy and David G. Maloney. These partnerships have further advanced her research and contributed to the development of effective therapeutic strategies.
Conclusion
Jeanette Dilley's contributions to the field of immunotherapy through her patents on monoclonal anti-idiotype antibodies highlight her role as a leading innovator in cancer treatment. Her work not only showcases her expertise but also offers hope for patients battling B-cell tumors.